A #COVID19 mRNA #vaccine based on self-amplifying RNA (saRNA) technology may offer a solution to the common barriers of cost and storage that prevent many countries from obtaining these vaccines. For more, read the #QPS #blog.

Arcturus Therapeutics recently completed a placebo-controlled trial of their self-amplifying COVID-19 mRNA vaccine, ARCT-154, in Vietnam.